Company intelligence
Opella
Health. In Your Hands.
About Opella
Opella is the self-care challenger with the purest and third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people’s hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world’s most loved brands, including Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale and Mucosolvan. As a globally certified B Corp company, we are active players in the journey towards healthier people and planet. Find out more about our mission on our website.
Verified activity
Signals from Opella
11 published signals
Legal & Regulatory
Opella recognized Essentiale's inclusion in the National Essential Medicines List 2026, serving approximately 10 million patients across China and reaching over 20 million boxes nationwide.
Reported by Opella
Research & Knowledge
Opella Scientist Denis Guyonnet published a piece in Pharmacy Times breaking down what probiotic labels are still failing to tell people who need them.
Reported by Opella
Research & Knowledge
Opella developed an MVP exploring how agentic AI can support an OTC barrier-repair opportunity and identify emerging opportunities such as GLP-1-related muscle health.
Reported by Harish Mahalingam, PhD
Presence & Recognition
Opella participated in the International Pharmaceutical Federation (FIP) Congress in Montreal, listening to pharmacists discuss patient health literacy and trust in OTC companies.
Reported by David Bircher
Presence & Recognition
Opella received the 2025 Best Innovation of the Year Award for its work as Innovation Project Manager on the launch of Cortizone-10 Fast Acting Itch Relief Cooling Spray.
Reported by Luis A. Fortin
Presence & Recognition
Opella participated in Day 3 of FIP Congress 2026, where it amplified Clarity at the Counter with an expert roundtable discussing digital opinion leaders and health information accessibility.
Reported by Opella
People
Opella team members Philip Durocher, Jamie Whaley, Ajay G., Leonardo Ilha, MaryAnne Dunlap, Suzanne J.nlap, Suzanne J., Greg Tole, Kevin Hazel, Helen Meldrum, PhD, Kishore Karuppan, Joanne Izzo, and Maria Ayres are part of the Canadian team.
Reported by Greg Ross
Presence & Recognition
Opella participated in the second day of FIP Congress 2026 with a focus on the Clarity at the Counter theme.
Reported by Opella
People
Opella employees attend procurement hubs in Frankfurt, Germany, and Hungary, and in Barcelona, to get meals and conversations with teams.
Reported by Panos Anastasiou
Presence & Recognition
Opella successfully wrapped up its first day at FIP Congress 2026 in Montreal.
Reported by Opella
Presence & Recognition
Opella employee Cedric Elmaleh will be attending the DPW Amsterdam procurement conference this year.
Reported by Cedric ELMALEH